Search research articles
Contact Us
Filters
Showing results (231-240 of 531) with videos related to
Page
of 54
Sort By:
Clinical Pediatrics
|
November 23, 2016
Acceptance of Pharmacist-Driven Antimicrobial Stewardship Recommendations With Differing Levels of Physician Involvement in a Children's Hospital
Leah Molloy, Eric McGrath, Ronald Thomas, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2014
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations
Brian J Werth, Katie E Barber, Cortney E Ireland, et al.
Current Infectious Disease Reports
|
August 29, 2014
High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it
Jordan R Smith, Kimberly C Claeys, Katie E Barber, et al.
Antiviral Research
|
June 16, 2004
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue
Deborah J Bidanset, Rachel J Rybak, Caroll B Hartline, et al.
Expert Opinion on Pharmacotherapy
|
May 19, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
Anthony M Casapao, Molly E Steed, Donald P Levine, et al.
Organic Letters
|
October 23, 2009
Synthesis and antibacterial properties of (-)-nor-platencin
Olga V Barykina, Kerri L Rossi, Michael J Rybak, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1995
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model
S M Palmer, S L Kang, D M Cappelletty, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1992
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin
K C Lamp, M J Rybak, E M Bailey, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2007
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
Thomas P Lodise, Peggy S McKinnon, Donald P Levine, et al.
DICP : the Annals of Pharmacotherapy
|
July 1, 1990
Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s
E M Bailey, T D Constance, L M Albrecht, et al.
Page
of 54
Search research articles
Search
Showing results (231-240 of 531) with videos related to
Sort By:
Page
of 54
Clinical Pediatrics
|
November 23, 2016
Acceptance of Pharmacist-Driven Antimicrobial Stewardship Recommendations With Differing Levels of Physician Involvement in a Children's Hospital
Leah Molloy, Eric McGrath, Ronald Thomas, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2014
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations
Brian J Werth, Katie E Barber, Cortney E Ireland, et al.
Current Infectious Disease Reports
|
August 29, 2014
High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it
Jordan R Smith, Kimberly C Claeys, Katie E Barber, et al.
Antiviral Research
|
June 16, 2004
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue
Deborah J Bidanset, Rachel J Rybak, Caroll B Hartline, et al.
Expert Opinion on Pharmacotherapy
|
May 19, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
Anthony M Casapao, Molly E Steed, Donald P Levine, et al.
Organic Letters
|
October 23, 2009
Synthesis and antibacterial properties of (-)-nor-platencin
Olga V Barykina, Kerri L Rossi, Michael J Rybak, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1995
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model
S M Palmer, S L Kang, D M Cappelletty, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1992
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin
K C Lamp, M J Rybak, E M Bailey, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 2007
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
Thomas P Lodise, Peggy S McKinnon, Donald P Levine, et al.
DICP : the Annals of Pharmacotherapy
|
July 1, 1990
Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s
E M Bailey, T D Constance, L M Albrecht, et al.
Page
of 54